Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production (Q39446077)

12 September 2017

Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production (English)

1 reference

12 September 2017

0 references

Yoon Sin Oh

1

1 reference

12 September 2017

Youn-Jung Lee

series ordinal

2

1 reference

12 September 2017

Eun Young Park

series ordinal

3

1 reference

12 September 2017

Hee-Sook Jun

series ordinal

4

1 reference

12 September 2017

1 November 2011

1 reference

Diabetes - Metabolism: Research and Reviews

12 September 2017

1 reference

12 September 2017

27

1 reference

12 September 2017

8

1 reference

12 September 2017

813-819

1 reference

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

12 September 2017

1 reference

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

An immune origin of type 2 diabetes?

21 January 2018

1 reference

IL-6 signal transduction and its physiological roles: the signal orchestration model

21 January 2018

1 reference

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

21 January 2018

1 reference

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

21 January 2018

1 reference

Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.

21 January 2018

1 reference

IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo

21 January 2018

1 reference

Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion

21 January 2018

1 reference

Janus kinase 2: a critical target in chronic myelogenous leukemia

21 January 2018

1 reference

Interleukin-6: discovery of a pleiotropic cytokine

21 January 2018

1 reference

Increased number of islet-associated macrophages in type 2 diabetes.

21 January 2018

1 reference

Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase

21 January 2018

1 reference

Interleukin-6 protects MIN6 beta cells from cytokine-induced apoptosis

21 January 2018

1 reference

Interleukin-6 regulates pancreatic alpha-cell mass expansion

21 January 2018

1 reference

STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line

21 January 2018

1 reference

Alpha 2-macroglobulin functions as a cytokine carrier to induce nitric oxide synthesis and cause nitric oxide-dependent cytotoxicity in the RAW 264.7 macrophage cell line

21 January 2018

1 reference

Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes

21 January 2018

1 reference

7 January 2021

Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro

1 reference

7 January 2021

A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability

1 reference

7 January 2021

Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1233

1 reference

12 September 2017

1 reference